Processa Pharmaceuticals, Inc. Accounts Payable and Accrued Liabilities
Processa Pharmaceuticals, Inc. (PCSA) had Accounts Payable and Accrued Liabilities of $2.25 million as of 2017-06-30, per its 10-Q filed 2017-10-04.
Discontinued › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent · last filed 2017-10-04
- 2017-06-30: Accounts Payable and Accrued Liabilities $2.25M.
- 2017-03-31: Accounts Payable and Accrued Liabilities $2.12M.
- 2016-12-31: Accounts Payable and Accrued Liabilities $2.05M.
- 2016-09-30: Accounts Payable and Accrued Liabilities $1.99M.
| Period end | Accounts Payable and Accrued Liabilities |
|---|---|
| 2017-06-30 | $2.25M 10-Q · filed 2017-10-04 |
| 2017-03-31 | $2.12M 10-Q · filed 2017-10-04 |
| 2016-12-31 | $2.05M 10-K · filed 2017-09-25 |
| 2016-09-30 | $1.99M 10-Q · filed 2017-09-08 |
| 2016-06-30 | $1.93M 10-Q · filed 2017-08-30 |
| 2016-03-31 | $1.59M 10-Q · filed 2017-08-07 |
| 2015-12-31 | $1.53M 10-K · filed 2017-06-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |